IQVIA director granted 1,571 deferred shares
Kaelin William G Jr reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kaelin William G Jr reported acquisition or exercise transactions in this Form 4 filing.
IQVIA Holdings Inc. director William G. Kaelin Jr. received a grant of 1,571 deferred shares on April 23, 2026. Each deferred share represents the right to receive one share of IQVIA common stock upon settlement under the company’s Non-Employee Director Deferral Plan.
The deferred shares become settleable when he ceases to be a director, upon a change in control of the company, or upon his death. After this award, he beneficially holds 1,571 deferred shares directly, with no stated expiry date on the award.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Shares | 1,571 | $160.68 | $252K |
Footnotes (1)
- F1. Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date.
Key Figures
Key Terms
Non-Employee Director Deferral Plan financial
change in control financial
settlement financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did IQV director William G. Kaelin Jr. report on this Form 4 for IQV?
AI-generated analysis. How Rhea-AI works. Not financial advice.